{
    "2020-03-04": [
        [
            {
                "time": "2020-03-15",
                "original_text": "Biopharma companies race to create coronavirus vaccine",
                "features": {
                    "keywords": [
                        "Biopharma",
                        "companies",
                        "coronavirus",
                        "vaccine"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biopharma"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-11-20",
                "original_text": "Alnylam's Givlaari Gets Approval in Europe for Rare Disease",
                "features": {
                    "keywords": [
                        "Alnylam",
                        "Givlaari",
                        "Approval",
                        "Europe",
                        "Rare Disease"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-12-01",
                "original_text": "The Zacks Analyst Blog Highlights: Merck, Novartis, Mondelez International, ServiceNow and General Dynamics",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Merck",
                        "Novartis",
                        "Mondelez International",
                        "ServiceNow",
                        "General Dynamics"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "consumer goods",
                        "technology",
                        "defense"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}